Antisoma to present at Piper Jaffray Health Care Conference
20 June 2006, London, UK – Cancer drug developer Antisoma plc(LSE: ASM; USOTC: ATSMY) today announces that Glyn Edwards, its Chief Executive Officer, will present at Piper Jaffray’s first London Health Care Conference on Friday 23 June at 12.00 BST.
Background on Antisoma
Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.
WebWireID15441
- Contact Information
- Margherita Lupi
- Communications Manager
- Antisoma plc
- Contact via E-mail
This news content was configured by WebWire editorial staff. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.